30 September 2021, Online
Brain Sciences | Advances in Neuropsychiatric Systemic Lupus Erythematosus
Neuropsychiatric (NP) systemic lupus erythematosus (SLE) is one of the most challenging organ involvements in this condition. Unfortunately, none of the NP manifestations that occur in SLE have features that are specific for SLE; therefore, determining the correct diagnosis is a challenging and critical step in order to decide the adequate treatment of individual patients, and in the performance of research studies.
Currently, newer and more advanced neuroimaging technologies are helping in both diagnosis and follow up. Additionally, advances in our knowledge of the main pathogenetic pathways (ischemic and neuroinflammatory mechanisms) allows for a better selection of therapies (antithrombotic or anti-inflammatory/immunomodulatory drugs). Furthermore, a multidisciplinary expert team approach is, without doubt, the best strategy for managing NPSLE.
However, there are still many unmet needs in the management of NPSLE (absence of diagnostic biomarkers, lack of novel therapies, paucity of clinical trials, etc.), which will be the scope of the present webinar of Brain Sciences.
The following experts will be present and talk:
- Prof. Dr. Ricard Cervera, Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain
- Professor Marcello Govoni, Department of Rheumatology, University of Ferrara, Italy
- Dr. Giovanni Sanna, Louise Coote Lupus Unit, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
- Dr. Chaim Putterman, Albert Einstein College of Medicine, Jack and Pearl Resnick Campus, USA
When? 30 September 2021 at 10:00am CEST | 4:00am EDT | 4:00pm CST Asia
Interested in contributing to the topic? You can find the Special Issue(s) linked to this topic and open for submission by clicking here.